These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3371 related items for PubMed ID: 15026990

  • 21. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
    Galipeau J, Li H, Paquin A, Sicilia F, Karpati G, Nalbantoglu J.
    Cancer Res; 1999 May 15; 59(10):2384-94. PubMed ID: 10344748
    [Abstract] [Full Text] [Related]

  • 22. [Suicide gene therapy for glioma using HSV-tk/GCV system].
    Xu L, Ge K, Zheng Z.
    Zhonghua Zhong Liu Za Zhi; 1997 Sep 15; 19(5):353-7. PubMed ID: 10920915
    [Abstract] [Full Text] [Related]

  • 23. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J, Moreno J, Sanchez-Perez L, Kottke T, Thompson J, Caruso M, Diaz RM, Vile R.
    Gene Ther; 2006 Oct 15; 13(20):1457-70. PubMed ID: 16724095
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
    Guan J, Ma L, Wei L.
    Chin Med J (Engl); 2001 Feb 15; 114(2):147-51. PubMed ID: 11780195
    [Abstract] [Full Text] [Related]

  • 27. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
    Pasanen T, Hakkarainen T, Timonen P, Parkkinen J, Tenhunen A, Loimas S, Wahlfors J.
    Int J Mol Med; 2003 Oct 15; 12(4):525-31. PubMed ID: 12964030
    [Abstract] [Full Text] [Related]

  • 28. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
    Kuriyama N, Kuriyama H, Julin CM, Lamborn KR, Israel MA.
    Cancer Res; 2001 Mar 01; 61(5):1805-9. PubMed ID: 11280727
    [Abstract] [Full Text] [Related]

  • 29. Avian adenovirus vector CELO-TK displays anticancer activity in human cancer cells and suppresses established murine melanoma tumors.
    Shashkova EV, Cherenova LV, Kazansky DB, Doronin K.
    Cancer Gene Ther; 2005 Jul 01; 12(7):617-26. PubMed ID: 15761475
    [Abstract] [Full Text] [Related]

  • 30. [Effects of adenovirus-mediated HSV-tk/GCV system on lens epithelium].
    Wang B, Weng J.
    Zhonghua Yan Ke Za Zhi; 2002 Oct 01; 38(10):618-22. PubMed ID: 12487913
    [Abstract] [Full Text] [Related]

  • 31. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
    Moriuchi S, Oligino T, Krisky D, Marconi P, Fink D, Cohen J, Glorioso JC.
    Cancer Res; 1998 Dec 15; 58(24):5731-7. PubMed ID: 9865731
    [Abstract] [Full Text] [Related]

  • 32. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA, Lamb C, Hogan S, Smiley WR, Kleinschmidt-Demasters BK, Burrows FJ.
    Cancer Gene Ther; 2000 Jan 15; 7(1):118-27. PubMed ID: 10678364
    [Abstract] [Full Text] [Related]

  • 33. Adenovirus-mediated gene therapy of experimental gliomas.
    Perez-Cruet MJ, Trask TW, Chen SH, Goodman JC, Woo SL, Grossman RG, Shine HD.
    J Neurosci Res; 1994 Nov 01; 39(4):506-11. PubMed ID: 7884826
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y, Deb NJ, Garg M, Kabarriti R, Alfieri A, Takahashi M, Roy-Chowdhury J, Guha C.
    Radiat Res; 2014 Aug 01; 182(2):191-200. PubMed ID: 24972258
    [Abstract] [Full Text] [Related]

  • 36. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K, Sandmair AM, Turunen M, Vanninen R, Vainio P, Kauppinen R, Johansson R, Vapalahti M, Ylä-Herttuala S.
    Cancer Gene Ther; 2002 Nov 01; 9(11):917-24. PubMed ID: 12386830
    [Abstract] [Full Text] [Related]

  • 37. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
    Zhao Y, Zhang X, Hui H.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun 01; 7(2):113-5. PubMed ID: 10488424
    [Abstract] [Full Text] [Related]

  • 38. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
    Tsuchiyama T, Kaneko S, Nakamoto Y, Sakai Y, Honda M, Mukaida N, Kobayashi K.
    Cancer Gene Ther; 2003 Apr 01; 10(4):260-9. PubMed ID: 12679798
    [Abstract] [Full Text] [Related]

  • 39. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y, Xu CJ, Liu XS, Wu CQ, Zhong CP, Gu JR.
    Ai Zheng; 2005 Aug 01; 24(8):909-14. PubMed ID: 16086864
    [Abstract] [Full Text] [Related]

  • 40. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
    He J, Chen Y, Li H, Lu Y, Yan Y, Tan X.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun 01; 21(3):428-32. PubMed ID: 15250149
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 169.